| 06/30/2009 |
Hospital Settings Should Be Exempt from Risk Evaluation and Mitigation Requirements for Opioid Drugs, ASHP Tells FDA [PDF] |
| 07/02/2009 |
Changes to Acetaminophen Formulations May Disrupt Care, ASHP Tells FDA
|
| 06/20/2008 |
Society Encourages FDA to Consult Pharmacists for Drug Safety Planning |
| 06/18/2008 |
ASHP to FDA: DTC Ads Should Point Viewers to MedWatch |
| 06/03/2009 |
Society Speaks Out on Strategies to Prevent Opiod Abuse |
| 06/03/2009 |
ASHP Urges FDA to Ensure Compliance with Consumer Drug Info Guidelines
|
| 04/23/2009 |
ASHP Calls on FDA to Engage Pharmacists in Efforts to Address Unapproved Drugs
|
| 04/06/2009 |
ASHP Calls on FDA to Improve Consumer Drug Information
|
| 03/27/2009 |
ASHP Advises DEA on Disposal Regulations
|
| 03/13/2009 |
ASHP Pushes for Medication Review for All Part D Patients
|
| 03/11/2009 |
ASHP Champions Safety in Pharmaceutical Waste Comments
|
| 02/13/2009 |
ASHP Calls for Changes to Dietary Supplement Safety Review Process
|
| 01/30/2009 |
Withdraw Propoxyphene from the U.S. Market, ASHP Tells FDA
|
| 01/29/2009 |
Society Aims to Enhance Study of Side Effect Reporting Tool
|
| 01/14/2009 |
ASHP Submits Comments to FDA Regarding Sentinel Initiative [PDF] |
| 03/27/2009 |
ASHP Advises DEA on Disposal Regulations |
| 01/29/2009 |
Society Aims to Enhance Study of Side Effect Reporting Tool |
| 01/14/2009 |
ASHP Submits Comments to FDA Regarding Sentinel Initiative |
| 12/30/2008 |
ASHP Comments to FDA on MedWatch Plus Portal |
| 12/05/2008 |
ASHP Calls for Removal of Propoxyphene From the U.S. Market |
| 06/20/2008 |
Society Encourages FDA to Consult Pharmacists for Drug Safety Planning
|
| 06/18/2008 |
ASHP Asks State Affiliates to Pursue Delay of Troublesome NDC Requirement |
| 06/18/2008 |
ASHP to FDA: DTC Ads Should Point Viewers to MedWatch
|
| |
|